• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TRP
Click for more information
1.89% 26.0¢

TISSUE REPAIR LTD - Charts / Financials

Market Cap $29.02M  ! watchlist Created with Sketch. Add to my watchlist

Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company... Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company developing second generation wound healing agents. The Company's core focus is entering Phase 3 clinical trials in chronic wounds for its lead drug candidate TR987, with a secondary focus on commercializing TR Pro+ a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its TR Pro+ product provides a range of benefits that assists damaged skin to heal and maintains skin hydration for a moist healing environment to encourage normal scar formation. The Company is also focused on commercializing its propriety Glucoprime active pharmaceutical ingredient (API) to treat a variety of wounds and skin conditions. Glucoprime is a β-glucan molecule, which is designed to assist skin healing and is delivered topically in a hydrogel formulation.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 21/11/2024 (20 minute delay) ?
Day
Open 26.5¢   Day High 26.5¢   Day Low 25.5¢
Daily Volume 33590
Bids   Sellers
Number Price Volume   Number Price Volume
1 25.5¢ 15000   1 28.5¢ 40000

Directors & Senior Management

Mr. Tony Charara Chief Executive Officer, Co-Founder, Executive Director
Mr. Cameron Jones Chief Financial Officer
Dr. Darryl Reed Chief Operating Officer
Mr. William Bost Vice President - Manufacturing
Dr. Pramod Nednoor Vice President - Chemistry and Controls
Mr. Mark Waring Vice President - Clinical and Regulatory Affairs
Ms. Sushma Kejriwal Company Secretary
Mr. Jack Lowenstein Independent Non-Executive Chairman of the Board
Dr. Michael Silberberg Non-Executive Director
Mr. Bryan Gray Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
26.0¢ 		Change
-0.005(1.89%) 		Mkt cap ! $29.02M
Open High Low Value Volume
26.5¢ 26.5¢ 25.5¢ $8.743K 33.59K

Buyers (Bids)

No. Vol. Price($)
1 15000 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 40000 1
View Market Depth
Last trade - 12.08pm 21/11/2024 (20 minute delay) ?
Last
25.5¢ 		  Change
-0.005 ( 1.92 %)
Open High Low Volume
26.0¢ 26.0¢ 25.5¢ 2413
Last updated 15.59pm 21/11/2024 ?

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.